Insights into serum metabolic biomarkers for early detection of incident diabetic kidney disease in Chinese patients with type 2 diabetes by random forest
Figure 1.The pipeline of this study. Three independent cohorts were recruited to perform the metabolite biomarker in discovery, validation and follow-up groups, respectively.